Sophia Randolph
2023
In 2023, Sophia Randolph earned a total compensation of $1.4M as Chief Medical Officer at ALX ONCOLOGY HOLDINGS, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,000 |
|---|---|
| Option Awards | $461,652 |
| Salary | $510,000 |
| Stock Awards | $199,240 |
| Total | $1,374,892 |
Randolph received $510K in salary, accounting for 37% of the total pay in 2023.
Randolph also received $204K in non-equity incentive plan, $461.7K in option awards and $199.2K in stock awards.
Rankings
In 2023, Sophia Randolph's compensation ranked 864th out of 2,983 executives tracked by ExecPay. In other words, Randolph earned more than 71.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 864 out of 2,983 | 71st |
Division Manufacturing | 507 out of 1,637 | 69th |
Major group Chemicals And Allied Products | 345 out of 906 | 62nd |
Industry group Drugs | 336 out of 869 | 61st |
Industry Pharmaceutical Preparations | 227 out of 627 | 64th |
Source: SEC filing on April 22, 2024.
Randolph's colleagues
We found three more compensation records of executives who worked with Sophia Randolph at ALX ONCOLOGY HOLDINGS in 2023.